The relationship between insight and subjective experience in schizophrenia

Código QR

The relationship between insight and subjective experience in schizophrenia

Yuki Kako, Koki Ito, Naoki Hashimoto, Kuniyoshi Toyoshima, Yusuke Shimizu, Nobuyuki Mitsui, Yutaka Fujii, Teruaki Tanaka, Ichiro Kusumi Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Japan Objectives: To examine the relationship between level of insig...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kako Y, Ito K, Hashimoto N, Toyoshima K, Shimizu Y, Mitsui N, Fujii Y, Tanaka T, Kusumi I
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f3a9e2fb10ec4e1abc979ae46610f3f3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia
por: Kim JH, et al.
Publicado: (2015)

The Role of Cognitive Complaints in the Relationship Between Trait Anxiety, Depressive Symptoms, and Subjective Well-Being and Ill-Being in Adult Community Volunteers
por: Toyoshima K, et al.
Publicado: (2021)

Does Subjective Cognitive Function Mediate the Effect of Affective Temperaments on Functional Disability in Japanese Adults?
por: Toyoshima K, et al.
Publicado: (2020)

Relationship between social and cognitive functions in people with schizophrenia
por: Tominaga T, et al.
Publicado: (2018)

The structural equation analysis of childhood abuse, adult stressful life events, and temperaments in major depressive disorders and their influence on refractoriness
por: Toda H, et al.
Publicado: (2015)

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
por: &Uuml;nsal C, et al.
Publicado: (2013)

Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report
por: Kitaichi Y, et al.
Publicado: (2013)

Evaluation Of Subjective Cognitive Function Using The Cognitive Complaints In Bipolar Disorder Rating Assessment (COBRA) In Japanese Adults
por: Toyoshima K, et al.
Publicado: (2019)

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
por: Saruwatari J, et al.
Publicado: (2013)

Early prediction of blonanserin response in Japanese patients with schizophrenia
por: Kishi T, et al.
Publicado: (2014)

Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia
por: Kikuchi YS, et al.
Publicado: (2014)

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
por: Oda Y, et al.
Publicado: (2015)

Absent activation in medial prefrontal cortex and temporoparietal junction but not superior temporal sulcus during the perception of biological motion in schizophrenia: a functional MRI study
por: Hashimoto N, et al.
Publicado: (2014)

Differences between bipolar and unipolar depression on Rorschach testing
por: Kimura H, et al.
Publicado: (2013)

Influence of patient characteristics on care time in patients hospitalized with schizophrenia
por: Sugibayashi Y, et al.
Publicado: (2014)

Reduced prefrontal cortex activation using the Trail Making Test in schizophrenia
por: Fujiki R, et al.
Publicado: (2013)

Profile of blonanserin for the treatment of schizophrenia
por: Tenjin T, et al.
Publicado: (2013)

Single event-related changes in cerebral oxygenated hemoglobin using word game in schizophrenia
por: Fujiki R, et al.
Publicado: (2014)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga K, et al.
Publicado: (2015)

Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia
por: Takahashi N, et al.
Publicado: (2013)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto K, et al.
Publicado: (2014)

Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first- episode or multi-episode schizophrenia
por: Washida K, et al.
Publicado: (2013)

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
por: Okayasu H, et al.
Publicado: (2021)

Cortical gyrification in schizophrenia: current perspectives
por: Matsuda Y, et al.
Publicado: (2018)

Altered heart rate dynamics associated with antipsychotic-induced subjective restlessness in patients with schizophrenia
por: Kim JH, et al.
Publicado: (2013)

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2016)

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
por: Zhao Y, et al.
Publicado: (2013)

An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia
por: Hirano J, et al.
Publicado: (2013)

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
por: Sliwa JK, et al.
Publicado: (2012)

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
por: Kishi T, et al.
Publicado: (2014)

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
por: Kishi T, et al.
Publicado: (2015)

Aripiprazole-associated tic in a schizophrenia patient
por: Guo X, et al.
Publicado: (2015)

Comprehensive family therapy: an effective approach for cognitive rehabilitation in schizophrenia
por: Cai J, et al.
Publicado: (2015)

Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population
por: Otsuka I, et al.
Publicado: (2015)

Jumping to conclusions in schizophrenia
por: Evans SL, et al.
Publicado: (2015)

Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
por: Beyazyüz M, et al.
Publicado: (2016)

Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function
por: Pan LH, et al.
Publicado: (2020)

The relationship between self-disgust, guilt, and flow experience among Japanese undergraduates
por: Hirao K, et al.
Publicado: (2013)

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data
por: Kuwabara H, et al.
Publicado: (2015)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda A, et al.
Publicado: (2013)